PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Completed · Phase 1

Conditions studied: Cancer

In brief

RATIONALE: PV701 may be able to kill tumor cells while leaving normal cells undamaged. PURPOSE: Phase I trial to study the effectiveness of PV701 in treating patients who have advanced or recurrent ovarian epithelial, fallopian tube, primary peritoneal, colorectal, or other cancer found primarily within the peritoneal cavity.

Key facts

Study ID

NCT00055705

Run by

Memorial Sloan Kettering Cancer Center

Starts

2003-01-01

Last updated by the study team

2011-04-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.